SK284841B6 - 12,13-Dihydroxyderiváty tylozínu a spôsob výroby - Google Patents
12,13-Dihydroxyderiváty tylozínu a spôsob výroby Download PDFInfo
- Publication number
- SK284841B6 SK284841B6 SK1241-99A SK124199A SK284841B6 SK 284841 B6 SK284841 B6 SK 284841B6 SK 124199 A SK124199 A SK 124199A SK 284841 B6 SK284841 B6 SK 284841B6
- Authority
- SK
- Slovakia
- Prior art keywords
- line
- hydrogen
- double bond
- och
- tylosin
- Prior art date
Links
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical class O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 238000006146 oximation reaction Methods 0.000 claims abstract description 7
- 230000007062 hydrolysis Effects 0.000 claims abstract description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 5
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 5
- 230000003647 oxidation Effects 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 27
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 150000001204 N-oxides Chemical class 0.000 claims description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 16
- 239000004182 Tylosin Substances 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 229960004059 tylosin Drugs 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 10
- 229930194936 Tylosin Natural products 0.000 claims description 10
- 235000019375 tylosin Nutrition 0.000 claims description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 8
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 claims description 6
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- 239000010439 graphite Substances 0.000 claims description 3
- 229910002804 graphite Inorganic materials 0.000 claims description 3
- 150000008282 halocarbons Chemical class 0.000 claims description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052753 mercury Inorganic materials 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 239000000047 product Substances 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 14
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 10
- 150000002923 oximes Chemical class 0.000 description 9
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 8
- 238000002211 ultraviolet spectrum Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- CELPHAGZKFMOMR-UHFFFAOYSA-N azanium;dichloromethane;methanol;hydroxide Chemical compound [NH4+].[OH-].OC.ClCCl CELPHAGZKFMOMR-UHFFFAOYSA-N 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Seasonings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR980496A HRP980496B1 (en) | 1998-09-10 | 1998-09-10 | New thilozine hydroxy derivatives and a process for the preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK124199A3 SK124199A3 (en) | 2000-12-11 |
| SK284841B6 true SK284841B6 (sk) | 2005-12-01 |
Family
ID=10946806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1241-99A SK284841B6 (sk) | 1998-09-10 | 1999-09-10 | 12,13-Dihydroxyderiváty tylozínu a spôsob výroby |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6211348B1 (cs) |
| EP (1) | EP0985679B8 (cs) |
| JP (1) | JP2000086691A (cs) |
| CN (1) | CN1150202C (cs) |
| AT (1) | ATE238331T1 (cs) |
| BG (1) | BG64561B1 (cs) |
| CA (1) | CA2281496C (cs) |
| CZ (1) | CZ294935B6 (cs) |
| DE (1) | DE69907101T2 (cs) |
| DK (1) | DK0985679T3 (cs) |
| ES (1) | ES2198102T3 (cs) |
| HR (1) | HRP980496B1 (cs) |
| HU (1) | HUP9903063A2 (cs) |
| NO (1) | NO312839B1 (cs) |
| PL (1) | PL195483B1 (cs) |
| RU (1) | RU2220149C2 (cs) |
| SI (1) | SI0985679T1 (cs) |
| SK (1) | SK284841B6 (cs) |
| UA (1) | UA66355C2 (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7247617B2 (en) | 2004-07-13 | 2007-07-24 | Kosan Biosciences Incorporated | Sixteen-member macrolide antiinfective agents |
| WO2006073172A1 (ja) * | 2005-01-07 | 2006-07-13 | Meiji Seika Kaisha, Ltd. | 12-オキシ-13-アミノ含有16員環マクロライド誘導体及びその製造法 |
| FR2891835B1 (fr) * | 2005-10-11 | 2007-12-14 | Alchimer Sa | Procede de modification de surfaces de polymeres, notamment d'hydroxylation de surfaces de polymeres, et produits tels qu'obtenus |
| CN117510561B (zh) * | 2023-11-30 | 2024-04-02 | 中国农业科学院饲料研究所 | 一种泰乐菌素衍生物及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG32649A1 (en) * | 1981-03-26 | 1982-09-15 | Kirov | Method for obtaining of antibiotic tilozine |
| AU551142B2 (en) * | 1981-07-09 | 1986-04-17 | Zaidan Hojin Biseibutsu Kagaku Kenkyukai | Tylosin derivatives |
| US4454314A (en) * | 1982-08-02 | 1984-06-12 | Pfizer Inc. | Antibacterial mycaminosyl tylonolide and related macrolide derivatives |
| EP0265735B1 (de) * | 1986-10-22 | 1991-01-16 | Ferag AG | Verfahren und Vorrichtung zum Übernehmen von gefalzten Druckereierzeugnissen von Druckmaschinen |
| SI8710674B (sl) * | 1987-04-14 | 1998-06-30 | Pliva | Postopek za pripravo 10,11,12,13-tetrahidro derivatov tilozina |
| DE4200145A1 (de) * | 1992-01-07 | 1993-07-08 | Kali Chemie Pharma Gmbh | 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JP3063943B2 (ja) * | 1992-02-26 | 2000-07-12 | 明治製菓株式会社 | 血漿中において抗菌活性の持続する新規１６員環マクロリド誘導体及びその合成中間体とそれらの製造法 |
| HRP950449A2 (en) * | 1995-08-14 | 1997-12-31 | Nevenka Lopotar | Derivatives of 12, 13-epoxy-tylosin and processes of manufacture thereof |
| HRP960509A2 (en) * | 1996-10-30 | 1998-06-30 | Pliva Pharm & Chem Works | Novel polyhydro tylosin derivatives and a process for the preparation thereof |
-
1998
- 1998-09-10 HR HR980496A patent/HRP980496B1/xx not_active IP Right Cessation
-
1999
- 1999-09-06 CZ CZ19993154A patent/CZ294935B6/cs not_active IP Right Cessation
- 1999-09-07 DK DK99117654T patent/DK0985679T3/da active
- 1999-09-07 SI SI9930319T patent/SI0985679T1/xx unknown
- 1999-09-07 AT AT99117654T patent/ATE238331T1/de not_active IP Right Cessation
- 1999-09-07 ES ES99117654T patent/ES2198102T3/es not_active Expired - Lifetime
- 1999-09-07 DE DE69907101T patent/DE69907101T2/de not_active Expired - Lifetime
- 1999-09-07 EP EP99117654A patent/EP0985679B8/en not_active Expired - Lifetime
- 1999-09-09 NO NO19994366A patent/NO312839B1/no unknown
- 1999-09-09 RU RU99119585/04A patent/RU2220149C2/ru not_active IP Right Cessation
- 1999-09-09 UA UA99095030A patent/UA66355C2/uk unknown
- 1999-09-09 CA CA002281496A patent/CA2281496C/en not_active Expired - Fee Related
- 1999-09-10 US US09/393,322 patent/US6211348B1/en not_active Expired - Fee Related
- 1999-09-10 CN CNB991220617A patent/CN1150202C/zh not_active Expired - Fee Related
- 1999-09-10 HU HU9903063A patent/HUP9903063A2/hu unknown
- 1999-09-10 BG BG103726A patent/BG64561B1/bg unknown
- 1999-09-10 JP JP11256906A patent/JP2000086691A/ja active Pending
- 1999-09-10 SK SK1241-99A patent/SK284841B6/sk unknown
- 1999-09-10 PL PL335362A patent/PL195483B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA66355C2 (en) | 2004-05-17 |
| DE69907101T2 (de) | 2004-04-08 |
| HRP980496A2 (en) | 2000-04-30 |
| HRP980496B1 (en) | 2007-03-31 |
| RU2220149C2 (ru) | 2003-12-27 |
| HUP9903063A2 (hu) | 2000-03-28 |
| DK0985679T3 (da) | 2003-08-11 |
| NO994366L (no) | 2000-03-13 |
| CN1150202C (zh) | 2004-05-19 |
| CN1250054A (zh) | 2000-04-12 |
| JP2000086691A (ja) | 2000-03-28 |
| NO312839B1 (no) | 2002-07-08 |
| DE69907101D1 (de) | 2003-05-28 |
| CZ294935B6 (cs) | 2005-04-13 |
| CZ315499A3 (cs) | 2000-04-12 |
| NO994366D0 (no) | 1999-09-09 |
| CA2281496A1 (en) | 2000-03-10 |
| SI0985679T1 (en) | 2003-10-31 |
| EP0985679B8 (en) | 2003-09-03 |
| ES2198102T3 (es) | 2004-01-16 |
| EP0985679A1 (en) | 2000-03-15 |
| BG103726A (en) | 2000-12-29 |
| ATE238331T1 (de) | 2003-05-15 |
| PL335362A1 (en) | 2000-03-13 |
| EP0985679B1 (en) | 2003-04-23 |
| BG64561B1 (bg) | 2005-07-29 |
| US6211348B1 (en) | 2001-04-03 |
| CA2281496C (en) | 2005-11-01 |
| SK124199A3 (en) | 2000-12-11 |
| PL195483B1 (pl) | 2007-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0253340B1 (en) | Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same | |
| EP0080818B1 (en) | Erythromycin b derivatives | |
| EP0287082B1 (en) | Derivatives of tylosin and 10,11,12,13-tetrahydro tylosin, methods of manufacture thereof and their use in pharmaceuticals and in the manufacture thereof | |
| NO784299L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-spectinomycylamin | |
| SK284841B6 (sk) | 12,13-Dihydroxyderiváty tylozínu a spôsob výroby | |
| KR19980702346A (ko) | 아미노 테트라론 유도체 및 그 제조방법 | |
| EP0410433A2 (en) | Tylosin derivatives | |
| HUT74883A (en) | New process and intermediates for preparing naphthyridonecarboxylic acid salts | |
| HU180298B (en) | Process for preparing new glycoside compunds | |
| US4895854A (en) | Antitumor alkaloids | |
| PL182429B1 (pl) | Pochodne 12,13-epoksy-tylozyny i sposób ich wytwarzania | |
| SK145097A3 (en) | Tylosine polyhydroderivatives and preparation method thereof | |
| FR2664894A1 (fr) | Nouveaux derives de streptogramines et leur preparation. | |
| WO2001077135A1 (en) | Process for preparing 6-methyl erythromycin a | |
| US20040063973A1 (en) | Process for preparing kifunensine intermediate and kifunensine therefrom | |
| CZ211798A3 (cs) | Lineární 8a-sekoazalidy a způsob jejich výroby | |
| SK283809B6 (sk) | Deriváty 2-azabicyklo[2.2.1]heptánu a spôsob ich prípravy | |
| NO320141B1 (no) | 3-deoksy-desmykosinderivater og fremgangsmate for deres fremstilling |